Distinguishing the specificities of closely related proteases - Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase

被引:50
作者
Ke, SH
Coombs, GS
Tachias, K
Navre, M
Corey, DR
Madison, EL
机构
[1] UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, HOWARD HUGHES MED INST, DALLAS, TX 75235 USA
[3] Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA
[4] AFFYMAX RES INST, SANTA CLARA, CA 95051 USA
关键词
D O I
10.1074/jbc.272.26.16603
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elucidating subtle specificity differences between closely related enzymes is a fundamental challenge for both enzymology and drug design, We have addressed this issue for two intimately related serine proteases, tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA), by modifying the technique of substrate phage display to create substrate subtraction libraries. Characterization of individual members of the substrate subtraction library accomplished the rapid, direct identification of small, highly selective substrates for t-PA. Comparison of the amino acid sequences of these selective substrates with the consensus sequence for optimal substrates for t-PA, derived using standard substrate phage display protocols, suggested that the P3 and P4 residues are the primary determinants of the ability of a substrate to discriminate between t-PA and u-PA. Mutagenesis of the P3 and P4 residues of plasminogen activator inhibitor type 1, the primary physiological inhibitor of both t-PA and u-PA, confirmed this prediction and indicated a predominant role for the P3 residue. Appropriate replacement of both the P3 and P4 residues enhanced the t-PA specificity of plasminogen activator inhibitor type 1 by a factor of 600, and mutation of the P3 residue alone increased this selectivity by a factor of 170. These results demonstrate that the combination of substrate phage display and substrate subtraction methods can be used to discover specificity differences between very closely related enzymes and that this information can be utilized to create highly selective inhibitors.
引用
收藏
页码:16603 / 16609
页数:7
相关论文
共 39 条
[1]   HYDROPHILIC-INTERACTION CHROMATOGRAPHY FOR THE SEPARATION OF PEPTIDES, NUCLEIC-ACIDS AND OTHER POLAR COMPOUNDS [J].
ALPERT, AJ .
JOURNAL OF CHROMATOGRAPHY, 1990, 499 :177-196
[2]  
BAGGIO R, 1996, BIOCHEMISTRY-US, V35, P3551
[3]  
BEATTY K, 1980, J BIOL CHEM, V255, P3931
[4]   GEOMETRY OF BINDING OF THE BENZAMIDINE-BASED AND ARGININE-BASED INHIBITORS N-ALPHA-(2-NAPHTHYL-SULFONYL-GLYCYL)-DL-PARA-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND (2R,4R)-4-METHYL-1-[N-ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)-L-ARGINYL]-2-PIPERIDINE CARBOXYLIC-ACID (MQPA) TO HUMAN ALPHA-THROMBIN - X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND MQPA-THROMBIN [J].
BODE, W ;
TURK, D ;
STURZEBECHER, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 193 (01) :175-182
[5]  
BODE W, 1992, PROTEIN SCI, V1, P426
[6]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[7]   P-NITROPHENYL-P'-GUANIDINOBENZOATE HCL - A NEW ACTIVE SITE TITRANT FOR TRYPSIN [J].
CHASE, T ;
SHAW, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 29 (04) :508-&
[8]  
COLLEN D, 1991, BLOOD, V78, P3114
[9]  
Coombs GS, 1996, J BIOL CHEM, V271, P4461
[10]   New drugs and changing disease paradigms - Commentary on drug development [J].
Crooke, ST .
NATURE BIOTECHNOLOGY, 1996, 14 (03) :238-&